Dr. Reiner Fuellmich & Karen Kingston - Corona Investigative Committee

June 25, 2022
Source: www.odysee.com/@Corona-Investigative-Committee:5/Session-110-Karen-Kingston-Odysee:7

Karen Kingston - Biotech Analyst and med-legal advisor with over 20 years of experience driving blockbuster commercialization efforts for medical devices and prescription therapies.

Owner of Varitage Strategies (since 2014)
Was once a Cardiovascular Sales Representative for the Northeast Region (NY) at Pfizer.

About:
- an Infants and Toddlers study by Pfizer: “It is statistically and clinically impossible to conduct a clinical trial that will prove a vaccine will be more effective than a child’s natural immune system.“
- BLA/FDA approval (not shielded by EUA research)
- new insights into the 2-SP Spike: “It’s a weaponized trimerized prefusion spike with 2 Proline modifications, aka optimized codons in Comirnaty and all other COVID-19 shots”
- About the Operation Warp Speed contracts, especially the DoD/Pfizer contract

The Corona Committee was founded on the initiative of attorney and economist Viviane Fischer and attorney Dr. Reiner Fuellmich. It is conducting a review of evidence on the Corona crisis and measures.

Learn more about the committee:
www.corona-investigative-committee.com